Streamlined Sample Preparation of a Drugs of Abuse Panel in Human Hair Using ISOLUTE® SLE+ Prior to UPLC-MS/MS Analysis

Importance of the Topic

The analysis of drugs of abuse in human hair offers a robust retrospective monitoring tool for forensic, clinical, and workplace testing. Streamlined workflows improve throughput, minimize sample loss, and enhance reproducibility in high-volume laboratories.

Objectives and Article Overview

This application note presents an optimized protocol for the extraction and cleanup of a 49-compound panel from human hair. It integrates mechanical micropulverization using Biotage Lysera with supported liquid extraction (ISOLUTE SLE+), eliminating intermediate evaporation steps to enable direct UPLC-MS/MS quantification.

Methodology and Instrumentation

• Sample Preparation: Weigh 20 mg hair, spike with deuterated internal standards, and extract in methanolic 0.1 % NH₄OH. Micropulverize in Biotage Lysera (3× 3 min at 5.3 m/sec).
• Supported Liquid Extraction: Transfer supernatant directly to ISOLUTE SLE+ columns or 200/400 µL plates. Elute sequentially with DCM/IPA (95:5) and MTBE under gravity and positive pressure.
• Post-Elution and Reconstitution: Evaporate at 40 °C in acidified methanol, then reconstitute in mobile phase A/B (80:20).
• UPLC-MS/MS Conditions: Shimadzu Nexera UHPLC with Restek Raptor Biphenyl column (100×2.1 mm, 2.7 µm). Gradient from 80:20 to 0:100 over 13.5 min; detection on Shimadzu 8060 triple quadrupole in positive ESI.

Main Results and Discussion

The protocol delivered average recoveries above 80 % with RSDs below 10 % across all analytes. Lower limits of quantification as low as 1 ng/mL (and sub-ng/mL for several compounds) were achieved. Calibration curves exhibited excellent linearity (r² > 0.995), and representative chromatograms showed clean baselines and consistent peak shapes at low concentrations.

Benefits and Practical Applications

This streamlined workflow reduces hands-on time and solvent consumption, avoids emulsions, and supports high-throughput screening of forensic and clinical hair samples. The combined Lysera-SLE approach is readily adaptable to automated platforms and diverse target panels.

Future Trends and Potential Applications

Emerging developments may include integration with high-resolution mass spectrometry, microfluidic SLE devices, and machine-learning–enabled data analysis. Expanded compound panels, miniaturized cartridges, and fully automated end-to-end systems will further enhance laboratory productivity and data quality.

Conclusion

The described method provides a rapid, reproducible, and sensitive solution for comprehensive drug screening in human hair. Its high recoveries, low variability, and compatibility with standard LC-MS/MS setups make it an attractive option for forensic and toxicological applications.

References

• Biotage Application Note AN897: Streamlined Sample Preparation of a Drugs of Abuse Panel in Human Hair Using ISOLUTE SLE+ and UPLC-MS/MS, 2018.